Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · First Trust

First Trust Indxx Medical Devices ETF (MDEV)

Ticker MDEV · Since 2021-06-22 · · Holdings as of Jun 30, 2026

Expense ratio
0.7%$70/yr per $10k
1-yr return
+2.0%as of Dec 2025
Net assets
$1.9Mall share classes
Holdings
51

Bottom line

Is MDEV a good fund? The bottom line

MDEV is an actively managed health care sector ETF from First Trust.

It charges 0.7% — about $70 a year on every $10,000 invested, cheaper than 69% of health care sector funds we track.

It returned +2.0% over one year (as of Dec 31, 2025, per its prospectus).

With $1.9 million in net assets and 51 holdings, its largest position is West Pharmaceutical Services Inc (2.9%) and the top 10 make up 25.5% of the portfolio.

What to watch

  • Small fund ($1.9 million) — small funds are likelier to close

Updated Nov 19, 2026

What MDEV invests in

The First Trust Indxx Medical Devices ETF (the Fund ) seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an index called the Indxx Medical Devices Index (the Index ).

Under normal market conditions, the Fund will invest at least 80% of its net assets (plus any investment borrowings) in the securities that comprise the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Fund will generally employ a full replication strategy, meaning that it will normally invest in all of the securities comprising the Index in proportion to their weightings in the Index. The Index is developed, maintained and sponsored by Indxx, Inc. (the Index Provider ). The Index Provider reserves the right to use qualitative judgment to include, exclude, adjust, or postpone the inclusion of a stock in the Index. Continued Index membership of a constituent is not necessarily subject to the guidelines provided in the Index methodology. A stock may be considered for exclusion by the Index Provider…

From the fund's prospectus (filed Jul 29, 2026).

MDEV performance

Fund calendar-year total returns, 2022–2025 2022: −28.4%; 2023: +7.2%; 2024: +2.2%; 2025: +2.0% −28.4% 2022 +7.2% 2023 +2.2% 2024 +2.0% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
MDEV+2.0%——
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full MDEV performance history →

What MDEV costs

On a $10,000 investment, MDEV's 0.7% expense ratio costs about $70 a year. The median health care sector fund charges 0.96%.

See the full MDEV fee table →

MDEV top 10 holdings

#Holding% of fund
1West Pharmaceutical Services Inc WST2.86%
2Demant A/s DEMANT2.70%
3Livanova Plc LIVN2.69%
4Baxter International Inc BAX2.55%
5Revvity Inc RVTY2.54%
6Straumann Holding Ag STMN2.53%
7Wuxi Apptec Co Ltd 23592.44%
8Waters Corp WAT2.40%
9Edwards Lifesciences Corp EW2.38%
10Agilent Technologies Inc A2.37%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 25.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to MDEV

More funds like MDEV →

MDEV FAQ

What is the expense ratio of MDEV?
MDEV's expense ratio is 0.7%, which works out to about $70 a year for every $10,000 invested.
Is MDEV a good investment?
It depends on your goals, but the data points to: small fund ($1.9 million) — small funds are likelier to close. This is general information, not personalized advice.
What does MDEV hold?
MDEV's largest holdings are West Pharmaceutical Services Inc (2.9%), Demant A/s (2.7%), Livanova Plc (2.7%), Baxter International Inc (2.5%), Revvity Inc (2.5%). It holds 51 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Who manages MDEV?
MDEV is offered by First Trust through First Trust Exchange-traded Fund Vi.